Test bank for focus on nursing pharmacology 7th edition byka
n n n n n n n n n n
rch all chapters
n n
Advanced Health Assessment (Walden University)
n n n n
, lOMoAR cPSD| 32744169
TestnBanknfornFocusnOnnNursingnPharmacologyn7thnEditio
n
Chaptern1:nIntroductionntonDrugs
CognitivenLevel:n ApplicationnDifficu
lty:n Moderate
IntegratednProcess:n Nursingnprocess
1.Annursenworkingninnradiologynadministersniodinentonanpatientnwhonisnhavingnancomput
erizednaxialntomographyn(CAT)nscan.nAnnursenworkingnonnannoncologynunitnadminist
ersnchemotherapyntonpatientsnwhonhavencancer.nAtnthenPublicnHealthnDepartment,nann
ursenadministersnanmeasles-mumps-rubellan(MMR)nvaccinentonan14-nmonth-
oldnchildnasnanroutinenimmunization.nWhichnbranchnofnpharmacologynbestndescribesnt
henactionsnofnallnthreennurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Response:
Pharmacologynisnthenstudynofnthenbiologicneffectsnofnchemicals.nNursesnareninvolvednwi
thnclinicalnpharmacologynornpharmacotherapeutics,nwhichnisnanbranchnofnpharmacology
nthatndealsn withnthen usesn ofndrugsn tontreat,n prevent,nandn diagnosendisease.nThennursenwor
kingninnradiologynisnadministeringnandrugntonhelpndiagnosenandisease.nThennursenworkin
gnonnannoncologynunitnisnadministeringnandrugntonhelpntreatnandisease.nPharmacoeconomi
csnincludesnanyncostsninvolvedninndrugntherapy.
Pharmacodynamicsninvolvesnhownandrugnaffectsnthenbody,nandnpharmacokineticsnisnhown
thenbodynactsnonnthendrug.
CognitivenLevel:nComprehensionnDif
ficulty:nEasy
IntegratednProcess:n Nursingnprocess
2.Anphysiciannhasnorderednintramuscularninjectionsnofnmorphine,nannarcotic,neveryn4nhour
snasnneedednfornpainnfornanmotornvehiclenaccidentnvictim.nThennursenisnawarenthatntherenis
nanhighnabusenpotentialnfornthisndrug;ntherefore,nmorphinenisncategorizednasna:
A) SchedulenIndrug
B) SchedulenIIndrug
C) SchedulenIIIndrug
D) SchedulenIVndrug
Ans: B
Response:
NarcoticsnsuchnasnmorphinenarenconsiderednschedulenIIndrugsnbecausenofnthenhighnabuse
npotentialnwithnseverendependencenliability.nSchedulenIndrugsnhavenhighnabusenpotentialn
andnnonacceptednmedicalnuse.nSchedulenIIIndrugsnhavenanlessernabusenpotentialnthannsche
dulenIIndrugsnandnannacceptednmedicalnuse.nSchedulenIVndrugsnhavenlownabusenpotentialn
andnlimitedndependencenliability.
CognitivenLevel:nComprehensionnDiffic
ulty:nEasy
IntegratednProcess:n Communicationnandndocumentation
3.A nursenworkingnfornandrugncompanynisninvolvedninnphasenIIIndrugnevaluationnstudies.n
Whichnofnthenfollowingnmightnthennursenbenresponsiblenfornduringnthisnstagenofndrugnde
velopment?
Pagen1
, lOMoAR cPSD| 32744169
TestnBanknfornFocusnOnnNursingnPharmacologyn7thnEditio
n
Chaptern1:nIntroductionntonDrugs
A) Workingnwithnanimalsnwhonarengivennexperimentalndrugs
B) Monitoringndrugneffectsninnpatientsnwhonarenselectedntonparticipateninnanstudy,nwho
nhaventhendiseasenthatnthendrugnisnmeantntontreat
C) Collectingnrecordsnofnsymptomsnthatnparticipantsnexperiencenwhilentakingnand
rugnandndeterminingnwhetherntheynarencausednbynthendiseasenornthendrugnInfor
D) mingnhealthy,nyoungnvolunteernparticipantsnofnpossiblenrisksnthatncouldnoccurn
fromntakingnannexperimentalndrug
Ans: C
Response:
PhasenIIInstudiesninvolvenusenofnandrugninnanvastnclinicalnmarketnwherenpatientsnarenaske
dntonrecordnanynsymptomsntheynexperiencenwhilentakingnthendrugs.nNursesnmaynbenrespo
nsiblenfornhelpingncollectnandnanalyzentheninformationntonbensharednwithnthenFoodnandn
DrugnAdministrationn(FDA).nUsenofnanimalsninndrugntestingnisndoneninnthenpreclinicalntr
ials.nAnselectngroupnofnpatientsnwhonareninvolvedninnphasenIInstudiesnparticipateninnstudi
esnwherenthenparticipantsnhaventhendiseasenthendrugnisnintendedntontreat.nThesenpatientsna
renmonitoredncloselynforndrugneffects.nPhasenInstudiesninvolvenhealthynhumannvolunteer
snwhonarenusuallynpaidnforntheirnparticipation.nNursesnmaynobservenfornadverseneffectsna
ndntoxicity.
CognitivenLevel:nComprehensionnDif
ficulty:n Moderate
IntegratednProcess:n NursingnProcess
4.Whichnofnthenfollowingnconceptsnisnconsiderednwhenngenericndrugsnarensubstitutednfornb
rand-namendrugs?
A) Bioavailability
B) Criticalnconcentration
C) Distribution
D) Half-life
Ans: A
Response:
Bioavailabilitynisnthenportionnofnandosenofnandrugnthatnreachesnthensystemicncirculationna
ndnisnavailablentonactnonnbodyncells.nBindersnusedninnangenericndrugnmaynnotnbenthensame
nasnthosenusedninnthenbrand-
namendrug.nTherefore,nthenwaynthenbodynbreaksndownnandnusesnthendrugnmayndiffer,nwhi
chnmayneliminatenansubstitution.nCriticalnconcentrationnisnthenamountnofnandrugnthatnisnne
ededntoncausenantherapeuticneffect.
Distributionnisnthenphasenofnpharmacokineticsnthatninvolvesnthenmovementnofnandrugntont
henbody'sntissues.nAndrug'snhalf-
lifenisnthentimenitntakesnfornthenamountnofndrugntondecreasentonone-halfnofnthenpeaknlevel.
CognitivenLevel:n Analysisn
Difficulty:n Difficult
IntegratednProcess:n Teaching/learning
5.A nursenisnteachingnhernpatientnaboutnthenusenofnover-the-
A) countern(OTC)ndrugs.nWhichnofnthenfollowingnstatementsnbestninformsnthenpatientnabout
ntheirnsafenuse?
B) “OTCndrugsnarenproductsnthatnarenavailablenwithoutnprescriptionnfornself-
treatmentnofnminorncomplaints.”
n
“OTCndrugsnarenconsiderednmedicationsnandnshouldnbenreportednonnandrugnh
istory.”
Pagen2
, lOMoAR cPSD| 32744169
TestnBanknfornFocusnOnnNursingnPharmacologyn7thnEditio
n
Chaptern1:nIntroductionntonDrugs
C) “OTCndrugsnwerenapprovednasnprescriptionndrugsnbutnlaternwerenfoundntonbens
afenwithoutnthenneednfornanprescription.”
D) “OTCndrugsnneedntonbentakennwithncaution.nTheyncannmasknthensignsnandnsympto
msnofnannunderlyingndiseasenandninterferenwithnprescriptionndrugntherapy.”
D
Ans: Response:
OTCndrugsnarenconsiderednmedicationsnandnshouldnbenreported.nOTCndrugsnarenavailabl
enwithoutnanprescription,nalthoughnsomenwerenfirstnapprovednasnprescriptionndrugs.nThen
mostnimportantnteachingnshouldnrelatentontheirnsafenusenandnthatnOTCndrugsncannmasknsy
mptomsnofndiseasenandninterferenwithnprescribedndrugs.
CognitivenLevel:nKnowledgenDifficul
ty:nEasy
IntegratednProcess:n NursingnProcess
6.WhichnofnthenfollowingnlegislativenactsnallowednthenFoodnandnDrugnAdministrationn(
FDA)ntontightenncontrolnovernthenqualitynofndrugsnandnrequirednthatnsafetynandneffica
cynstandardsnbenestablished?
A) PurenFoodnandnDrugnActnofn1906
B) FederalnFood,nDrug,nandnCosmeticnActnofn1938
C) DurhamnHumphreynAmendmentnofn1951
D) Kefauver-HarrisnActnofn1962
Ans: D
Response:
ThenKefauver-
HarrisnActnwasnthenresultnofnthenusenofnthen1960sndrugnthalidomiden(Thalomid).nThenpu
blicnconcernnledntonthenlegislationnthatngaventhenFDAnregulatoryncontrolnoverntestingnan
dnevaluatingnofndrugsnandnallowednitntonsetnstandardsnfornefficacynandnsafety.nThenPuren
FoodnandnDrugnActnrequirednlabelingntoneliminatenfalsenclaims.nThenFederalnFood,nDru
g,nandnCosmeticnActngaventhenFDAnthenpowerntonenforcenstandardsnforntestingndrugntox
icitynandnmonitoringnlabeling.nThenDurham-
nHumphreynAmendmentnenforcednprescriptionsnforndistribution.
CognitivenLevel:n ApplicationnDifficu
lty:n Moderate
IntegratednProcess:n Teaching/learning
7.Annursenisninstructingnanpregnantnpatientnconcerningnthenpotentialnriskntonhernfetusnfro
mnanpregnancyncategorynBndrug.nThennursenwouldninformnthenpatientnthat:
A) “Adequatenstudiesninnpregnantnwomennhavendemonstratedntherenisnnonriskntonthenf
etus.”
B) “Animalnstudiesnhavennotndemonstratednanriskntonthenfetusnbutntherenhavenbeennn
onadequatenstudiesninnpregnantnwomen.”
C) “Animalnstudiesnhavenshownnannadverseneffectnonnthenfetusnbutntherenarennona
dequatenstudiesninnpregnantnwomen.”
D) “Therenisnevidencenofnhumannfetalnrisknbutnthenpotentialnbenefitsnfromnusenofnthend
rugnmaynbenacceptablendespitenpotentialnrisks.”
Ans: B
Response:
CategorynBnindicatesnthatnanimalnstudiesnhavennotndemonstratednanriskntonthenfetusnbut
Pagen3